RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

144 hedge funds and large institutions have $1.94B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$38.7M
Puts
$41.4M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$479K
102
$462K
103
$458K
104
$436K
105
$431K
106
$414K
107
$402K
108
$387K
109
$385K
110
$366K
111
$358K
112
$343K
113
$331K
114
$296K
115
$292K
116
$292K
117
$291K
118
$283K
119
$254K
120
$248K
121
$247K
122
$246K
123
$236K
124
$208K
125
$206K